CO5011092A1 - Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente - Google Patents

Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente

Info

Publication number
CO5011092A1
CO5011092A1 CO98003337A CO98003337A CO5011092A1 CO 5011092 A1 CO5011092 A1 CO 5011092A1 CO 98003337 A CO98003337 A CO 98003337A CO 98003337 A CO98003337 A CO 98003337A CO 5011092 A1 CO5011092 A1 CO 5011092A1
Authority
CO
Colombia
Prior art keywords
substituted
free base
product mixture
azabicyclooxime
formula
Prior art date
Application number
CO98003337A
Other languages
English (en)
Inventor
Mark Alan Schwindt
Lloyd Charles Franklin
Tecle Haile
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of CO5011092A1 publication Critical patent/CO5011092A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)

Abstract

Un proceso para el aislamiento de éteres de oximaazabiciclo en alta pureza Z; dicho proceso comprende:a) hacer reaccionar una hidroxilamina O-substituidade fórmula R-CºC-CH-O-NH donde R es aril o heteroaril C4 -12 substituido o sinsubstituir:con una azabiciclocetona de la fórmula:donde n = 1 ó 2 y donde la configuración estereoquímica es R, S, o R/S cuando n es 1;en una solución acuosa para formar una mezcla de producto de isómeros Z y E de éteres azabiciclooxima sustituido -CH2-CºC-R; b) añadir en forma contemporánea o secuencial uno o más ácidos efectivos para enriquecer dicha mezcla de producto en el isómero Z del mencionado éter azabiciclooxima substituido CH2 -CºC-R;c) elevar el pH de dicha mezcla de producto a un pH efectivo para liberar la base libre del éter azabiciclooxima -CH2 -C C-R sustituido; d) extraer la base libre mencionada con un solvente no acuoso de solubilidad en agua limitada; e) añadir un ácido formante de sal a dicha base libre disuelta en un solvente no acuoso y f) recuperar una sal de éster azabiciclooxima (Z) pura.
CO98003337A 1997-01-27 1998-01-26 Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente CO5011092A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3597797P 1997-01-27 1997-01-27

Publications (1)

Publication Number Publication Date
CO5011092A1 true CO5011092A1 (es) 2001-02-28

Family

ID=21885887

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98003337A CO5011092A1 (es) 1997-01-27 1998-01-26 Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente

Country Status (21)

Country Link
US (1) US6121459A (es)
EP (1) EP1021446A1 (es)
JP (1) JP2001511127A (es)
KR (1) KR20000070464A (es)
AR (1) AR011775A1 (es)
AU (1) AU741566B2 (es)
BR (1) BR9714469A (es)
CA (1) CA2270884A1 (es)
CO (1) CO5011092A1 (es)
GT (1) GT199800019A (es)
HR (1) HRP980040B1 (es)
IL (1) IL129793A (es)
MY (1) MY132840A (es)
NZ (1) NZ335784A (es)
PA (1) PA8445601A1 (es)
PE (1) PE75499A1 (es)
SV (1) SV1998000003A (es)
TW (1) TW533215B (es)
UY (1) UY24857A1 (es)
WO (1) WO1998032758A1 (es)
ZA (1) ZA98618B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5583592B2 (ja) * 2007-11-30 2014-09-03 ニューリンク ジェネティクス コーポレイション Ido阻害剤
FR2938534B1 (fr) 2008-11-14 2012-10-26 Sanofi Aventis Procede de preparation de l'hemifumarate d'eplivanserine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158015A (en) * 1978-08-16 1979-06-12 Mobil Oil Corporation Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
AU2782792A (en) * 1991-10-15 1993-05-21 Warner-Lambert Company Azabicyclo oxime and amine cholinergic agents and methods of treatment
DE4203170A1 (de) * 1992-02-05 1993-08-12 Basf Ag Verfahren zur herstellung von e-oximethern von phenylglyoxylsaeureestern
IL107881A0 (en) * 1992-12-05 1994-04-12 Fisons Corp Furanone derivatives and pharmaceutical compositions containing them
US5514812A (en) * 1994-06-10 1996-05-07 Warner-Lambert Company Preparation of stereochemically pure oximes with muscarinic activity

Also Published As

Publication number Publication date
PE75499A1 (es) 1999-08-20
SV1998000003A (es) 1998-08-13
PA8445601A1 (es) 2000-05-24
UY24857A1 (es) 1998-06-25
HRP980040A2 (en) 1998-10-31
BR9714469A (pt) 2000-05-16
NZ335784A (en) 2000-12-22
AU5806598A (en) 1998-08-18
HRP980040B1 (en) 2002-10-31
TW533215B (en) 2003-05-21
IL129793A (en) 2003-01-12
JP2001511127A (ja) 2001-08-07
AU741566B2 (en) 2001-12-06
US6121459A (en) 2000-09-19
CA2270884A1 (en) 1998-07-30
AR011775A1 (es) 2000-09-13
GT199800019A (es) 1999-07-20
MY132840A (en) 2007-10-31
WO1998032758A1 (en) 1998-07-30
KR20000070464A (ko) 2000-11-25
EP1021446A1 (en) 2000-07-26
ZA98618B (en) 1998-07-30
IL129793A0 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
TNSN88012A1 (fr) Procede de preparation de l'enantiomere dextrogyre de l'alpha (tetrahydro-4,5,6,7 thieno (3,2-c) pyridyl - 5) (chloro -2 phenyl) acetate de methyle
KR950032045A (ko) 비누화된 금잔화 함유수지로부터 얻는 루테인의 분리, 정제 및 재결정방법
CA2211939A1 (en) Process for producing rhein and diacerhein
CO5011092A1 (es) Proceso para producir eters de oxima (z)-azabiciclo en un unico recipiente
US3641123A (en) Substituted amides of 4-aryl-3-hydroxy butyric acids
UY24945A1 (es) Proceso para preparar haluros de acido o-(3-amino-2-hidroxi- propil)-hidroximico
AR036018A1 (es) Proceso para aislar monohidrato de imipenem cristalino puro
HUP0204111A2 (hu) Új eljárás alfa-(2,4-diszulfo-fenil)-N-terc-butil-nitron és gyógyszerészetileg elfogadható sói előállítására
AR041057A1 (es) Sintesis y purificacacion de nateglinida
GB808425A (en) Improvements in or relating to the separation of aromatic amines
US2316825A (en) p-nitrobenzene sulphinamide
JPS53108933A (en) Production of amidinoformic acid derivative
KR960700232A (ko) 신규시클로프로필유도체, 그 제조방법 및 용도(new cyclopropyl deri vatives, preparation method thereof and applications)
GB1102300A (en) Preparation of l-ª‡-amino-ª‡-methyl-3,4-disubstituted phenyl propionamides and the corresponding acids
GB1132699A (en) A process for the production of sulphones and polysulphones
JPS55151536A (en) New optically active tert-leucine d-10-camphasulfonic acid salt and its preparation
JPS5419903A (en) New preparation of amino
CA2389595A1 (en) Improved synthesis of n,n-disubstituted-p-phenylenediamine
JPH0374347A (ja) シス・トランス混合菊酸の光学分割法
JPS51138602A (en) Process for preparing alpha-hydrazino carboxylic acids
JPS54128523A (en) 3-guanidinoamino propionic acid and its preparation
AR037588A1 (es) Preparacion de sales de amonio de acidos carboxilicos aromaticos
KR840003812A (ko) 치료 작용을 갖는 d-2-(6-메톡시-2-나프틸)-프로 피온산 유도체의 제조방법 및 이들을 함유하는 약리학적 조성물
JPS5257111A (en) Process for organic carboxylic acid silver
JPS5522699A (en) Novel 3-amino-1-benzylpyrrolidine derivative